The global erythropoietin (EPO) drugs market in the forecast period 2022-2029. The expected CAGR of global erythropoietin (EPO) drugs market is tend to be around 12% in the mentioned forecast period. The market was valued at USD 6.50 billion in 2021, and it would grow upto USD 16.09 billion by 2029.
Market Definition
Erythropoietin (EPO) is known as haemopoietin, a hormone produced endogenously by the kidneys that plays an essential role in red blood cells (RBCs) production. Erythropoietin (EPO) medications are widely used in the treatment of anemia. The main aim behind the development of the erythropoietin drug was to treat patients with anaemic conditions arising from end-stage renal disease (ESRD). EPO treatment has been shown to activate antioxidants, stimulate neurogenesis, and anti-inflammatory signaling pathways, thus increasing the therapeutic benefits and supporting the market growth.
Market Segmentation
Drug Type (Biologics, Biosimilars), Drugs (Epoetin-Alfa, Darbepoetin-Alfa, Epoetin-Beta, Others), Indication (Cancer, Neurology, Hematology, Renal diseases, Others), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy).
Global Erythropoietin (EPO) Drugs Market Scope
The global erythropoietin (EPO) drugs market is segmented on the basis of indication, drugs, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Get Full Access of Sample Report:- https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-erythropoietin-epo-drugs-market
Erythropoietin (EPO) Drugs Market Regional Analysis/Insights
The global erythropoietin (EPO) drugs market is analysed and market size insights and trends are provided by indication, drugs, distribution channel and end-user as referenced above.
The major countries covered in the global erythropoietin (EPO) drugs market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Key players operating in the global erythropoietin (EPO) drugs market include:
· Pfizer Inc (U.S.)
· AstraZeneca (U.K.)
· Bristol-Myers Squibb Company (U.S.)
· Dr. Reddy's Laboratories Ltd (India)
· Endo International plc (Ireland)
· Teva Pharmaceutical Industries Ltd (Israel)
· Sun Pharmaceutical Industries Ltd (India)
· Mylan N.V. (U.S.)
· Novartis AG (Switzerland)
· Lupin (India)
· Cipla Inc (India)
· Shanghai Dahua Pharmaceutical Co., Ltd (China)
· JCR Pharmaceuticals Co., Ltd (Japan)
Major Toc of the Repot
Chapter one:- Market Introduction
Chapter Two:- Market Definition
Chapter Three:- Market Segmentation
Chapter Four:- Market Scope & Analysis
Get Toc Details:- https://www.databridgemarketresearch.com/toc/?dbmr=global-erythropoietin-epo-drugs-market
Browse Related Reports
Global Dermatology Drugs Market
Global Immunotherapy Drugs Market
Global Performance Enhancing Drugs Market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek